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Salmonella enterica serovar Typhimurium is a facultative intracellular pathogen that causes disease in mice that
resembles human typhoid. Typhoid pathogenesis consists of distinct phases in the intestine and a subsequent systemic
phase in which bacteria replicate in macrophages of the liver and spleen. The type III secretion system encoded by
Salmonella pathogenicity island 2 (SPI-2) is a major virulence factor contributing to the systemic phase of typhoid
pathogenesis. Understanding how pathogens regulate virulence mechanisms in response to the environment,
including different host tissues, is key to our understanding of pathogenesis. A recombinase-based in vivo expression
technology system was developed to assess SPI-2 expression during murine typhoid. SPI-2 expression was detectable
at very early times in bacteria that were resident in the lumen of the ileum and was independent of active bacterial
invasion of the epithelium. We also provide direct evidence for the regulation of SPI-2 by the Salmonella transcription
factors ompR and ssrB in vivo. Together these results demonstrate that SPI-2 expression precedes penetration of the
intestinal epithelium. This induction of expression precedes any documented SPI-2-dependent phases of typhoid and
may be involved in preparing Salmonella to successfully resist the antimicrobial environment encountered within
macrophages.
Citation: Brown NF, Vallance BA, Coombes BK, Valdez Y, Coburn BA, et al. (2005) Salmonella pathogenicity island 2 is expressed prior to penetrating the intestine. PLoS
Pathog 1(3): e32.
Introduction
Salmonella is a Gram-negative bacterial pathogen that
causes substantial morbidity and mortality worldwide. Hu-
man-adapted serovars cause typhoid, a systemic and life-
threatening infection, while non-human-adapted serovars
commonly cause enteritis. Following ingestion of contami-
nated food or water, the pathogenesis of both typhoid and
Salmonella enteritis begins with an intestinal phase, while only
typhoid progresses to a systemic phase. The intestinal phase
of typhoid involves colonization of the intestine and
penetration of the intestinal epithelium through two separate
mechanisms. The ﬁrst involves active bacterial invasion [1],
and the second involves passive uptake of Salmonella during
dendritic cell (DC) sampling of luminal microﬂora [2,3]. Once
Salmonella has penetrated the intestinal epithelium, the
systemic phase of typhoid begins by dissemination from the
intestine via the lymphatics followed by colonization of
macrophages of the liver and spleen [4,5]. The niche occupied
by Salmonella within these cells is a membrane-bound
compartment termed the Salmonella-containing vacuole.
Much of our understanding of typhoid pathogenesis has
come from mice infected with S. enterica serovar Typhimu-
rium, which models human typhoid in several respects.
The current understanding of typhoid pathogenesis sug-
gests that distinct virulence systems operate during the
intestinal and systemic phases of infection and that these
virulence systems display little overlap in their spatiotempo-
ral activation. These virulence factors are type III secretion
systems (T3SSs) that translocate numerous Salmonella viru-
lence proteins (termed effectors) directly into the host cell,
where they alter various host cell processes [6]. The T3SS
encoded by Salmonella pathogenicity island 1 (SPI-1) allows
Salmonella to invade non-phagocytic cells and penetrate the
intestinal epithelium, and is the major factor involved during
the intestinal phase of typhoid [7–9]. SPI-1 mutant Salmonella
Typhimurium is fully virulent when inoculated intraperito-
neally into mice, indicating that the role played by SPI-1 is
limited to the intestinal phase of Salmonella infection [9]. In
contrast, Salmonella pathogenicity island 2 (SPI-2) mediates
Salmonella replication within macrophages at systemic sites,
and SPI-2 mutant Salmonella is avirulent when inoculated
intraperitoneally [10–12]. Studies of Salmonella-induced enter-
itis have found that the role of SPI-2 in the intestine is subtle
when compared to the role of SPI-1 [13–16]. However, it
should be noted that Salmonella-induced enteritis and typhoid
are distinct diseases involving different intestinal pathologies,
and as such the pathogenesis of the diseases is not directly
comparable. In particular, typhoid does not typically involve
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models in which Salmonella employs a two-tiered expression
of virulence systems that correspond to the biphasic patho-
genesis of typhoid, with SPI-1 mediating intestinal patho-
genesis and SPI-2 mediating systemic pathogenesis.
While it is clear that SPI-2 is a major virulence factor
leading to mortality in murine typhoid, our current under-
standing of its molecular function is limited. Its primary role
appears to be subversion of host cell membrane trafﬁc,
allowing replication of intracellular Salmonella [17]. Consis-
tent with its role during intracellular growth, in vitro studies
have shown that expression of SPI-2 is induced inside host
cells and in culture medium that mimics the environment of
the Salmonella-containing vacuole [18–20]. In vitro, SPI-2
expression is regulated by the SPI-2-encoded regulatory
system SsrA/B [18,19], and efﬁcient transcription of ssrAB
requires the regulator OmpR [21]. Recent work by Hensel and
colleagues has shown that the SPI-2 T3SS is typically
expressed as one apparatus per bacterium, during growth
in host cells or during inducing in vitro culture [22].
Countless studies have shown that bacteria regulate their
expression proﬁle by sensing the extracellular environment
and responding accordingly. As an environment in which to
study bacterial gene expression, the mammalian host poses
unique challenges because of its complexity and dynamic
nature. Consequently, analysis of the spatiotemporal expres-
sion pattern of virulence genes in vivo has rarely been
undertaken. Of particular interest to the ﬁeld of Salmonella
research is the expression pattern of SPI-2 during typhoid
because it is the central virulence mechanism and is
considered to play a role speciﬁc to a particular phase of
pathogenesis. Based on this, we hypothesized that SPI-2
expression would be conﬁned to the peripheral lymphoid
tissues, spleen, and liver. To address this, we examined the
spatiotemporal expression pattern of three SPI-2 promoters
during experimental murine typhoid. In contrast to the
current model of SPI-2-mediated pathogenesis that argues
for exclusive intracellular expression, we found that expres-
sion of SPI-2 occurs during initial stages of pathogenesis in
the lumen of the intestine.
Results
SPI-2 Gene Expression In Vitro Assessed Using RIVET
Recombinase-based in vivo expression technology (RIVET)
is an exquisitely sensitive reporter of gene expression. This
system involves the construction of a transcriptional fusion to
a site-speciﬁc recombinase, which mediates the loss of a
selectable genetic marker (a process called resolution) [23].
This approach has been applied to elucidate the spatiotem-
poral expression patterns of the toxin-coregulated pilus and
cholera toxin during Vibrio cholerae infection of mice [24]. We
designed and constructed a Salmonella Typhimurium strain
possessing all the genetic requirements for RIVET and lacZ
fusion analysis of PsseA (see Materials and Methods). The
ability of this strain to function as a RIVET reporter of PsseA
activity was initially assessed during in vitro growth in media
that have previously been shown to induce (LPM medium) or
not induce (Luria-Bertani [LB] medium) expression from SPI-
2 promoters (Figure 1). PsseA activity was assessed using RIVET
and b-galactosidase activity as well as by monitoring
cytoplasmic levels of SseB, a protein expressed from PsseA.A
low level of PsseA activity was detected for each output in the
non-inducing LB medium whereas high levels were detected
from bacteria cultured in the inducing LPM medium,
indicating that RIVET correlates well with standard methods.
Additionally, RIVET was considerably more sensitive at
detecting PsseA activity than lacZ transcriptional fusion and
immunoblotting for native SseB levels. This was most obvious
when the number of bacteria in the culture was below the
sensitivity of conventional reporter systems. Furthermore,
the high degree of sensitivity of RIVET was deemed
important for the study of the monocopy expression level
of the SPI-2 T3SS. Using RIVET, we also conﬁrmed the role of
SsrB and OmpR in regulating SPI-2 gene expression (Figure
1D).
Salmonella infection of cultured mammalian cells is a model
that is frequently used to approximate conditions encoun-
tered during infection in vivo. We determined the expression
from PsseA at 1 h following uptake into various mammalian
cells using the RIVET system (Figure 2). In HeLa cells
(epithelial), where bacteria actively induce their own uptake
using the SPI-1 T3SS, substantial induction of expression
from PsseA occurred after 1 h in an SsrB- and an OmpR-
dependent fashion. This demonstrates that SPI-2 is activated
rapidly following SPI-1-mediated Salmonella invasion of an
epithelial cell. The role of SPI-2 in mediating replication
within macrophages has been thoroughly documented [17],
and DCs are also a potentially important cell type encoun-
tered by Salmonella in vivo [2,3]. We therefore determined the
kinetics of PsseA induction in RAW264.7 murine macrophages
and murine DCs. A signiﬁcant induction of SsrB- and OmpR-
dependent PsseA expression could be detected within 1 h of
Salmonella being added to either cell type (Figure 2).
SPI-2 Gene Expression In Vivo Assessed Using RIVET
Once it was established that the RIVET system was sensitive
and speciﬁc, the RIVET system was used to determine the
spatiotemporal expression pattern of PsseA during infection of
mice. To facilitate the synchronized arrival of a bacterial load
in the distal ileum, the inoculum was delivered into a single
loop constructed in the ileum of each mouse tested (see
Materials and Methods). At times ranging from 15 min to 4 h
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Synopsis
Typhoid fever is a disease caused by specific Salmonella strains and
is a significant cause of mortality in many regions of the developing
world. Following a person’s ingestion of Salmonella, the bacteria
initially colonize the intestine, which they subsequently breach to
reside in immune cells of the liver and spleen. The ability to survive
inside immune cells directly contributes to the ability of Salmonella
to cause typhoid, and is conferred upon Salmonella by the so-called
Salmonella pathogenicity island 2 (SPI-2) type III secretion system.
Previous work has shown that while SPI-2 is specifically turned on
inside host cells, it is not active when grown in typical laboratory
medium. Owing to these facts, it has been hypothesized that
Salmonella specifically turn on SPI-2 inside host cells after breaching
the host intestine. The researchers developed a sensitive system in
Salmonella to test this hypothesis using a mouse model of typhoid.
Interestingly, SPI-2 was specifically turned on before Salmonella
breached the intestine, suggesting that SPI-2, which is integral to
virulence, is active in a preemptive fashion to allow Salmonella to
survive within the immune system.following inoculation, the liver, spleen, mesenteric lymph
nodes, and ileal loop were dissected, homogenized, and plated
to determine the degree of PsseA induction using RIVET
(Figure 3A). These results clearly demonstrated that expres-
sion from PsseA was induced within 15 min following
inoculation and that this induction occurred within the
ileum. RIVET reports gene expression in an irreversible
fashion, and data on expression at systemic sites and later
time points was not considered reliable as the majority of
bacteria had undergone resolution within 15 min. We also
assessed ssrB
  and ompR
  strains for their ability to induce
expression from PsseA within the ileum 15 min following
inoculation (Figure 3B). These data showed that both
regulators play a signiﬁcant role in the observed induction
in the ileum and directly showed the involvement of these
regulators in the expression of SPI-2 in vivo.
The experiments described above showed that PsseA, the
promoter driving expression of the SPI-2 T3SS translocon
and effectors, is active within 15 min of inoculation into ileal
loops. To see if the promoters driving expression of the
remaining components of the SPI-2 T3SS were active on a
similar timescale, we constructed strains for RIVET analysis
of transcription from PspiC and PssaG. These strains were
conﬁrmed to have the typical SPI-2 expression characteristics
during in vitro culture, including being dependent on the
SPI-2-encoded transcription factor SsrB (data not shown).
When these strains were inoculated into mouse ileal loops,
expression after 15 min from both PspiC and PssaG could be
observed (Figure 3C), similar to that of previous experiments
with PsseA. These results showed that all SPI-2 T3SS
components are expressed in a large proportion of Salmonella
within 15 min of arriving in the ileum.
The short time frame in which SPI-2 expression was
induced in vivo prompted us to investigate the location of
Figure 1. Expression from PsseA during Growth of Salmonella in Inducing
and Non-Inducing Culture Media
(A–C) The wild-type Salmonella RIVET strain (NB25) was inoculated into
LPM (inducing) and LB (non-inducing) media at 1/100 of the culture
volume, and cultures were incubated with shaking at 37 8C. At the
indicated time points, samples were taken for measurement of culture
OD600 (unpublished data), colony-forming units per millilitre (unpub-
lished data), b-galactosidase activity, percent resolution, and native SseB
levels. The results shown for percent resolution (A) and b-galactosidase
activity (B) are the mean 6 standard error of the mean from three
independent experiments. The levels of SseB associated with bacteria
were detected by immunoblotting (C). Protein loading was normalized
Figure 2. Expression from PsseA during Infection of Mammalian Cells In
Vitro
The human epithelial cell line HeLa, murine macrophage cell line
RAW264.7, and bone-marrow-derived DCs were infected with wild-type
(NB25), ssrB
  (NB7), and ompR
  (NB15) RIVET strains as described in
Materials and Methods. At 1 h post-infection intracellular bacteria were
recovered and the percent resolution was determined.
DOI: 10.1371/journal.ppat.0010032.g002
to culture OD600 and was confirmed by immunoblotting for the
abundantly expressed cytoplasmic protein DnaK.
(D) Wild-type (NB25), ssrB
  (NB7), and ompR
  (NB15) were grown in LPM
mediumandpercentresolutionwas determinedfromthe culturesat10h.
DOI: 10.1371/journal.ppat.0010032.g001
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SPI-2 Expression In Vivothe bacteria that had induced SPI-2 expression. Speciﬁcally,
we wanted to know whether Salmonella was located within host
cells when SPI-2 expression was induced. As SPI-1 mediates
the major route of epithelial penetration [2,8], we tested
expression from PsseA in a SPI-1 mutant (invA
 ) in vivo. At 15
min following inoculation, the induction of expression from
PsseA was independent of SPI-1 (Figure 4A), strongly suggest-
ing that the SPI-2 expression we were observing was
occurring in the lumen of the intestine. To further test this,
we directly determined the localization of wild-type Salmonella
15 min following inoculation into ileal loops using confocal
microscopy. As expected, the vast majority of bacteria were
not located within host cells but rather were associated with
the apical surface of the epithelium (Figure 4B). These data
are inconsistent with the observed induction of SPI-2
occurring exclusively in an intracellular compartment in vivo.
To test whether Salmonella association with the cytoplasmic
membrane of a host cell initiates expression from PsseA, we
infected HeLa cells in vitro with noninvasive invA
  Salmonella.
Extracellular, cell-associated invA
  Salmonella at 1 h post-
infection had not induced signiﬁcant expression from PsseA
(3.54% 6 3.01% resolution). In contrast, internalized wild-
type Salmonella controls showed a high level of expression
(75.10% 6 5.75% resolution). This is consistent with cell
culture medium providing a non-inducing environment for
SPI-2 expression (data not shown) and shows that the host cell
plasmalemma does not induce SPI-2 expression. This
suggested that a stimulus for expression from PsseA exists in
the luminal contents of the small intestine. We therefore
conducted experiments to address this hypothesis. Wild-type,
ssrB
 , and ompR
  RIVET strains were incubated for up to 30
min at 37 8C with contents collected from mouse small
intestine and then resolution was measured. No resolution
was observed for any strain, suggesting that the stimulus
inducing expression of SPI-2 in the intestine is not capable of
being extracted with naive luminal contents of the small
intestine.
Discussion
By using a sensitive methodology and testing earlier time
points than have been presented in previous studies of SPI-2
function, we have established that SPI-2 genes are expressed
very early in the intestine. The data presented above are
inconsistent with the currently held view that the initial
induction of SPI-2 expression occurs in response to an
intracellular environment. Our attempts to conﬁrm the
RIVET expression data using b-galactosidase reporters to
measure SPI-2 expression in vivo failed to detect sufﬁcient
signal to reliably report SPI-2 expression (data not shown).
However, extensive controls were performed in vitro, where
sufﬁcient numbers of bacteria can be analyzed to detect b-
Figure 3. Kinetics of SPI-2 Expression during Murine Typhoid
(A) Mice were infected with the wild-type PsseA RIVET strain (NB25) as described in Materials and Methods. At the indicated times following inoculation,
the ileal loops, mesenteric lymph nodes, spleen, and liver were taken and assessed for expression from PsseA by determining the percent resolution. The
results shown are the mean 6 standard error of the mean from three independent experiments.
(B) Mice were infected with the wild-type (NB25), ssrB
  (NB7), and ompR
  (NB15) PsseA RIVET strains, and at 15 min following inoculation, the ileal loop
was removed and homogenized, and the percent resolution of the infecting Salmonella was determined.
(C) Mice were infected with the wild-type PspiC (NB33) and PssaG (NB31) RIVET strains for 15 and 30 min, the ileum was removed and homogenized, and
the percentage resolution determined. The results shown are the mean 6 standard error of the mean for three independent experiments.
DOI: 10.1371/journal.ppat.0010032.g003
Figure 4. Salmonella Induces Expression of SPI-2 in the Lumen of the
Ileum
(A) Mouse ileal loops were infected with either wild-type or invA
  PsseA
RIVET strains for 15 min before the loops were removed and
homogenized, and the percent resolution was determined.
(B) Mouse ileal loops were infected with wild-type Salmonella for 15 min
before being removed, fixed, stained, and analyzed by confocal
microscopy with an oil immersion 403 1.3 N.A. objective. A representa-
tive image is displayed showing host cell nuclei in blue, actin in green,
and Salmonella in red.
DOI: 10.1371/journal.ppat.0010032.g004
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SPI-2 Expression In Vivogalactosidase reporters as well as SPI-2 proteins by western
blotting. These control experiments conﬁrmed that RIVET
was a sensitive and speciﬁc reporter of SPI-2 expression. The
failure of b-galactosidase to accurately report on SPI-2
expression in vivo is most likely a reﬂection of low bacterial
numbers in the examined tissues. This highlights a major
advantage of RIVET in its capacity to report on gene
expression from small populations of bacteria.
Previous work has focused on mimicking the intracellular
environment encountered by Salmonella to deﬁne the cues for
inducing expression of SPI-2. Our results show that SPI-2 is
induced in the gut lumen, prior to encountering an intra-
cellular environment. We have investigated signals present in
the small intestine as potential cues for SPI-2 expression and
have determined that intestinal SPI-2 induction is not a result
of association with host cell plasmalemma or luminal
contents from the small intestine of uninfected mice. Addi-
tionally, we have been able to rule out low oxygen tension as a
cue for SPI-2 induction in the intestine (data not shown). Our
data are compatible with a rapid host response to Salmonella
acting as a cue for the induction of SPI-2 expression. One
such response would be the secretion of antimicrobial
products by paneth cells, specialized epithelial cells that
reside at the base of the crypts and respond to antigenic
stimuli including Salmonella [25]. However, experiments with
mmp7
 /  mice, which are deﬁcient in paneth cell products,
have indicated that these products are not a stimulus for SPI-
2 expression in vivo (data not shown). Other potential host
responses acting as a stimulus for SPI-2 expression will be a
topic of future investigation.
Previous studies on SPI-2 and its translocated effectors
have almost exclusively focused on the role played during the
systemic phase of typhoid, and consequently little is known
about the potential actions of SPI-2 during the intestinal
phase of typhoid. Others have shown that SPI-2 mutant
Salmonella colonizes the caecum and Peyer’s patches to a lesser
extent than wild-type Salmonella during typhoid [19]. This,
together with our data on expression, ﬁrmly establishes a role
for SPI-2 prior to colonization of systemic sites during
typhoid. It is important to consider the localization of
intestinal Salmonella in order to speculate on the role SPI-2
could be playing at this location. Although the vast majority
of bacteria are present in the luminal space of the intestine, it
is well established that Salmonella transits through epithelial
cells and can reside within sub-epithelial phagocytic cells.
Given that type III secretion mediates the direct delivery of
effector proteins into the host cell cytosol [6] and that the
system encoded by SPI-2 allows Salmonella to replicate within
macrophages [17], this suggests that the location where SPI-2
is actually functioning is within phagocytic cells of the
intestine. It is likely that SPI-2 expression initiated in the
intestinal lumen primes Salmonella for residency in intestinal
phagocytic cells prior to the bacteria reaching this niche. We
do not conclude that SPI-2 enables replication of luminal
Salmonella.
The rapid induction of SPI-2 in the lumen of the ileum
suggests that for Salmonella to initiate a successful infection of
sub-epithelial and systemic sites, it must be prepared for the
harsh environment of the macrophage endosomal system
prior to the encounter. This ﬁnding may establish a paradigm
for all pathogens where preemptive synthesis of important
virulence factors occurs prior to the transition from
colonization of a mucosal surface to colonization of systemic
sites. We also speculate that functions mediated by SPI-2
during early stages of infection may not be limited to the
establishment of a Salmonella-containing vacuole that sup-
ports bacterial replication. Such possibilities include enhanc-
ing dissemination to systemic sites. By identifying additional
SPI-2-dependent functions at these early intestinal stages of
typhoid pathogenesis, we hope to elucidate key mechanisms
that facilitate the successful parasitic lifestyle of Salmonella.
Materials and Methods
Bacterial strains and plasmids. Bacterial strains and plasmids are
shown in Table 1. All Salmonella strains used in this study were derived
from the wild-type strain SL1344. All bacteria were routinely cultured
in LB medium. LPM medium (pH 5.8) has been described previously
[26]. Kanamycin was used at 50 lgm l
 1, chloramphenicol at 10 lg
ml
 1, and ampicillin at 100 lgm l
 1. Salmonella RIVET strains were
always grown in LB medium containing ampicillin and chloramphe-
nicol prior to conducting experiments.
For RIVET studies, it is desirable to insert the resolvable cassette
(res-marker-res) into a neutral site within the genome. ushA is a silent
gene in Salmonella Typhimurium because of an inactivating S139Y
substitution in the expressed protein product [27], and as such this
was considered to be a good site to insert the resolvable cassette for
RIVET. A region of approximately 1.8 kb spanning ushA was
ampliﬁed by PCR using the oligonucleotides ushako-f (59 GCAAC
TAGTGCGATGTTGGAGATAGTAGGATGTG 39) and ushako-r (59
GATGTCGACCCTCACCATTTGGCGTAAACG 39) and was cloned
into pBLUESCRIPT KSþ using SpeI and SalI to create pUshA. A
resolvable cassette mediating resistance to chloramphenicol was
constructed by subcloning the res-npt-sacB-res-containing SphI frag-
ment into pUC19 to create pUC-RES. The npt-sacB portion was
replaced with cat to give pUC-RESCm. The res-cat-res cassette was then
inserted into the middle of ushA in pUshA, and then the ushA::res-cat-
res allele was cloned into pCVD442 using SacI and KpnI to give
pUshA::RES KO. Using this plasmid, the ushA::res-cat-res allele was
introduced into SL1344 and SL1344 DompR using standard allelic
exchange methodologies [28] to give strains NB24 and NB13,
respectively. NB24 was shown to have no detectable defect in
virulence when inoculated intraperitoneally into mice by either a
time-to-death assay (N. F. B. and B. A. V., unpublished data) or
competitive index (B. K. C. and M. Wickham, unpublished data).
Salmonella strains NB6 and NB16 were created by P22 generalized
transduction of ssrB::Km and invA::Km alleles into NB24, respectively.
Transcriptional fusions were generated as follows. An approx-
imately 1.5-kb region upstream of sseA was ampliﬁed by PCR using
oligonucleotides pssea-f (59 ATACTCGAGCGTATTCTTCATTTT
CATCGGTG 39) and pssea-r (59 ATACAATTGCCCTTTCAG
CAAGCTGTTGAC 39) and cloned into pIVET5nMut135 using XhoI
and MfeI. Other reporter strains were generated using the same
strategy using oligonucleotides pssagfu-f (59 ATGCTCGAGAAT
TACCTCCGTTAGCCTGAC 39) and pssagfu-r (59 ATG
CAATTGCTGCCTGGTGCGCCATGTG 39)f o rP ssaG and
oligonucleotides pssab-f (59 ATTCTCGAGTCGGCGTGCAATTT
GAAGG 39) and pssab-r (59 ATACAATTGCCAGCAT
GAATCCCTCCTCAGAC 39)f o rP spiC.T h er e s u l t i n gr e p o r t e r
plasmids were conjugated into the desired Salmonella strains from
Escherichia coli SM10 kpir. The resulting strains had the reporter
plasmid integrated into the chromosome by homologous recombi-
nation, resulting in a merodiploid genotype for the promoter region
being studied.
Gene expression reporter assays. Resolutionassayswereperformed
by plating serial dilutionsof samplematerialonto LB ampicillin plates
and incubating these overnight at 37 8C. The following day, plates with
between 50 and 200 colonies were replica-plated onto LB ampicillin
plates and LB ampicillin chloramphenicol plates, which were incu-
bated overnight at 37 8C. Colonies that grew on the ampicillin only
plates, but not on the ampicillin chloramphenicol plates were
considered to have undergone the resolution event. b-galactosidase
assays were performed as previously described [29] using Galacto-Star
chemiluminescent substrate (Applied Biosystems, Foster City, Califor-
nia, United States) and were read using a Spectraﬂuor Plus (Tecan,
Mannedorf, Switzerland) in luminescence mode.
Antibodies and reagents. Antibodies to SseB have been described
previously [30] and were used at a concentration of 1:1,000, and a
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British Columbia, Canada) was used at a concentration of 1:2,000.
Anti-Salmonella Typhimurium LPS antiserum (Difco, Becton-Dick-
inson, Franklin Lakes, New Jersey, United States) was used at a
concentration of 1:200. HRP-labeled anti-mouse and anti-rabbit
antibodies were used at a concentration of 1:5,000 and were
purchased from Jackson Immunoresearch Laboratories (West Grove,
Pennsylvania, United States). Alexaﬂuor 568–labeled anti-rabbit
antibodies (Molecular Probes, Eugene, Oregon, United States) were
used at a concentration of 1:200. Alexaﬂuor 488–labeled phalloidin
and DAPI were purchased from Molecular Probes.
Cell culture and infection of cultured cells. HeLa and RAW264.7
cells were cultured using DMEM containing 10% FCS. Bone-marrow-
derived DCs were derived as previously described [31]. Brieﬂy, 2.5 3
10
6 bone marrow cells were cultured in 10 ml of Iscove’s Modiﬁed
Dulbeco’s Medium supplemented with 10% FCS, GM-CSF (20 ng/ml),
and IL-4 (10 ng/ml). The cells were harvested after 6 d of culture, and
DCs were puriﬁed using anti-CD11c conjugated MACS microbeads
and magnetic separation columns (Miltenyi Biotec, Bergisch Glad-
bach, Germany). The purity of DCs was assessed by FACS analysis and
ranged from 70% to 90% CD11c
þ. Cells were incubated in an
atmosphere containing 5% CO2 at 37 8C.
HeLa cells were infected with invasive Salmonella prepared
according to previous studies [32]. RAW264.7 and DCs were infected
with stationary phase Salmonella opsonized in 20% normal human
serum for 30 min. An incubation of 10 min at 37 8Ci n5 %C O 2 was
performed once bacteria were applied to cell cultures to allow for
internalization. Following this, the infecting medium was aspirated,
cells were washed four times with PBS, fresh cell culture medium
containing gentamicin (100 lgm l
 1) was added, and incubation at 37
8Ci n5 %C O 2 was continued. At 1 h post-infection, cell culture
medium was removed and the cells were again washed four times with
PBS. The cells were then lysed in a solution of Triton X-100 (1% v/v)
and sodium dodecyl sulfate (0.1% w/v) to release intracellular
bacteria. Samples were diluted and assayed for resolution.
Mouse infections. Female C57BL/6 mice (6–10 wk of age) were
purchased from Jackson Laboratory (Bar Harbor, Maine, United
States), and housed in the animal facility at the University of British
Columbia in direct accordance with guidelines drafted by the
University of British Columbia’s Animal Care Committee and the
Canadian Council on the Use of Laboratory Animals. For ileal loop
experiments, bacterial inocula of approximately 10
7 colony-forming
units were prepared in 100 ll, and the resolution status of the strain
was conﬁrmed directly before inoculation. Ileal loop experiments
were modiﬁed from those previously described [1]. In brief, mice
were anaesthetized by intraperitoneal injection of ketamine and
xylazine. Following a midline abdominal incision, the small bowel was
exposed and the bowel was ligated twice, close to the cecum, to create
a loop approximately 4 cm in length into which the inoculum was
injected. The bowel was then returned to the abdominal cavity and
the incision closed with discontinuous sutures. At given time points,
t h em i c ew e r ee u t h a n i z e da n dt i s s u e sc o l l e c t e df o rb a c t e r i a l
enumeration and RIVET. The intestinal lumen was rinsed with PBS
to remove non-adherent bacteria. Tissues were homogenized in PBS
using a Polytron homogenizer (Kinematica, Lucerne, Switzerland).
Immunohistochemistry. Tissues were ﬁxed for 3 h in 3%
paraformaldehyde, and washed three times with PBS prior to
cryoembedding and sectioning. Sections were ﬁxed in acetone at
 20 8C for 10 min and then air dried at room temperature. Tissue
sections were outlined with a wax pen and blocked 30 min in 10%
goat serum in PBS-BSA at room temperature. Sections were then
washed three times in PBS-BSA prior to incubation for 30 min at
room temperature with anti-Salmonella LPS antiserum. Sections were
then washed three times in PBS-BSA prior to incubation with
appropriate Alexaﬂuor 568–conjugated anti-rabbit antibodies. Sec-
tions were then washed three times in PBS-BSA, incubated with
Alexaﬂuor 488–labeled phalloidin, washed a further three times in
PBS-BSA, and then incubated in DAPI. Imaging was performed on a
Nikon (Tokyo, Japan) TE2000 inverted microscope equipped with a
Bio-Rad (Hercules, California, United States) Radiance 2000 confocal
Table 1. Bacterial Strains and Plasmids Used in This Study
Category Strain/Plasmid Genotype/Description Reference/Source
E. coli DH5a supE44 Dlacu169 (/80 lacZDM15) hsdR17 recA1 endA1 gyrA96 thi-1 relA1 [31]
SM10 kpir thi recA thr leu tonA lacY supE RP4–2–Tc::Mu kpir [32]
Salmonella SL1344 Wild-type strain [33]
SB103 invA::Km [9]
SL1344 DompR DompR B. B. F. (unpublished data)
SL1344 ssrB::Kan ssrB::Km [28]
NB6 ssrB::Km ushA::res-cat-res This study
NB7 ssrB::Km ushA::res-cat-res sseA::pPsseAMut135 This study
NB13 DompR ushA::res-cat-res This study
NB15 DompR ushA::res-cat-res sseA::pPsseAMut135 This study
NB16 invA::Km ushA::res-cat-res This study
NB23 invA::Km ushA::res-cat-res sseA::pPsseAMut135 This study
NB24 ushA::res-cat-res This study
NB25 ushA::res-cat-res sseA::pPsseAMut135 This study
NB31 ushA::res-cat-res ssaG::pPssaGMut135 This study
NB32 ssrB::Km ushA::res-cat-res ssaG::pPssaGMut135 This study
NB33 ushA::res-cat-res spiC::pPspiCMut135 This study
NB34 ssrB::Km ushA::res-cat-res spiC::pPspiCMut135 This study
Plasmid pRES lacZ::res-npt-sacB-res bla oriT oriR6K [34]
pIVET5nMut135 tnpR::lacZ bla oriT oriR6K [23]
p34S-Cm2 cat [35]
pCVD442 bla oriT oriR6K sacB [26]
pBLUESCRIPT KSþ oriColE1 oriF1(þ) bla lacZa Stratagene (La Jolla, California, United States)
pUC19 oriColE1 bla lacZa [36]
pUshA ushA. pBLUESCRIPT KSþ derivative This study
pUC-RES res-npt-sacB-res. pUC19 derivative This study
pUC-RESCm res-cat-res. pUC-RES derivative This study
pUshA::RES KO ushA::res-cat-res. pCVD442 derivative This study
pPsseAMut135 PsseA::tnpR::lacZ. pIVET5nMut135 derivative This study
pPssaGMut135 PssaG::tnpR::lacZ. pIVET5nMut135 derivative This study
pPspiCMut135 PspiC::tnpR::lacZ. pIVET5nMut135 derivative This study
DOI: 10.1371/journal.ppat.0010032.t001
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